Trial Profile
Phase I pharmacokinetic study of 2-methoxyestradiol (2ME2) in healthy volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2015
Price :
$35
*
At a glance
- Drugs 2-methoxyestradiol (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors CASI Pharmaceuticals
- 31 Mar 2015 New trial record
- 27 Mar 2015 This trial is expected to be initiated in 2015, according to a CASI Pharmaceuticals media release.